The Safety and Efficacy of Alpha-1 Antitrypsin (AAT) for the Prevention of Graft ‑Versus-host Disease (GVHD) in Patients Receiving Hematopoietic Cell Transplant

Condition:   Graft Versus Host Disease Interventions:   Biological: Alpha-1 antitrypsin (AAT);   Biological: Placebo Sponsor:   CSL Behring Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials